Observations in glioma animal models indicated that the expression of G9a can enhance the influx of IFN‐γ+CD4+ and CD8+ T cells, while simultaneously diminishing the entrance of PD‐1+CD4+ T cells, MDSCs and M2 macrophages within the TME. Here, CD4 is linked to central nervous system cancer.